IQE PLC
15 February 2002
15 February 2002
IQE plc ('the Group' or 'IQE')
Trading Update
The Board of Directors of IQE ('the Board'), the largest outsource manufacturer
of specialist epiwafers to the compound semiconductor industry, announces a
trading update ahead of the Group's fourth quarter and preliminary results
announcement to be made on 20 March 2002, against the background of continuing
uncertainty in the semiconductor markets.
The current trading environment continues to be extremely challenging,
particularly in the opto-electronic sector and the Board do not consider that
there will be any noticeable upturn until the second half of 2002. Component
manufacturers who are the main users of the Company's wafer products in this
sector continue to suffer from low demand and excess inventories as end user
capex spend continues to fall.
For the quarter ended 31 December 2001, the Group's turnover is likely to be
reported at the lower end of the market's expectations resulting in a turnover
for the full year to 31 December 2001 of around £42 million.
Although the two principal markets of opto-electronics and wireless have
remained depressed for most of the last 12 months, the revenue for full year
2001 is nonetheless likely to show some 40 per cent. increase over the full year
2000. At the pre tax level, and following an increased R+D spend to accelerate
development of the exciting new technologies the Company has, such as GaAs on
Silicon and Silicon Germanium, the Group expects to announce a net loss before
amortisation and exceptionals for the fourth quarter of 2001 of between £3.5m
and £3.8m. The net loss before amortisation and exceptionals for the full year
to 31 December 2001 is therefore likely to be in the region of £3.3m to £3.6m.
Outlook
Looking forward, in the first quarter of 2002 IQE has continued to experience an
extremely difficult trading environment due to the ongoing decline in the
opto-electronic communications industry and the fitful recovery in the wireless
sector. Although other areas of the business are moving ahead, such as optical
storage and silicon compounds, where successful qualifications are continuing to
be completed, the production ramp in these areas is not swift enough to offset
the decline in the optical communications products.
As a result, the Group anticipates trading for the first quarter of 2002 to be
lower than in Q4 2001, with a steady improvement in trading expected to flow
through in the second half of the year.
The Company continues to make good progress with materials under R&D,
particularly with the GaAs on Silicon Technology on which it has an exclusive
wafer supply licence from Motorola, and with Silicon Germanium (SiGe) based
products.
Following the placing and open offer of IQE's shares undertaken in December
2001, when the Group raised approximately £27.5 million (after expenses), the
Group has a healthy cash position of around £30 million. The Board believes that
as the semiconductor industry recovers, together with the exceptionally exciting
opportunity open to the Group as a result of its agreements with Motorola
relating to the commercialisation of the GaAs on Silicon Wafers, and as
outsourcing becomes a much more significant part of the compound semi-conductor
industry, IQE is well placed to consolidate its position as the leading
outsource wafer manufacturer within the semiconductor industry.
Commenting, Dr Drew Nelson, President and CEO, said
'Although trading remains very difficult at the present time, IQE has continued
to build a very powerful product portfolio. This is helping to create some
unique opportunities for the Company, such as exclusivity to the GaAs on Silicon
technology licensed from Motorola. Our cash position is strong, we are keeping
a tight control on costs and we do not require high levels of ongoing capex to
increase revenue significantly. As the market returns across the various
semiconductor sectors, we feel IQE is uniquely placed to benefit, particularly
as we believe outsourcing is poised to become a key theme with many companies. '
For further information, please contact:
Dr Drew Nelson, IQE 02920 839 400
Graham Meek, Beeson Gregory 020 7488 4040
Tim Thompson or Nicola Cronk, Buchanan 020 7466 5000
Communications
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.